<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Tissue Barriers</journal-id>
<journal-id journal-id-type="iso-abbrev">Tissue Barriers</journal-id>
<journal-id journal-id-type="publisher-id">KTIB</journal-id>
<journal-id journal-id-type="publisher-id">ktib20</journal-id>
<journal-title-group>
<journal-title>Tissue Barriers</journal-title>
</journal-title-group>
<issn pub-type="ppub">2168-8362</issn>
<issn pub-type="epub">2168-8370</issn>
<publisher>
<publisher-name>Taylor &amp; Francis</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28123927</article-id>
<article-id pub-id-type="pmc">5214347</article-id>
<article-id pub-id-type="publisher-id">1251384</article-id>
<article-id pub-id-type="doi">10.1080/21688370.2016.1251384</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Reviews</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Zonulin, a regulator of epithelial and endothelial barrier functions, and its involvement in chronic inflammatory diseases</article-title>
<alt-title alt-title-type="running-authors">C. STURGEON AND A. FASANO</alt-title>
<alt-title alt-title-type="running-title">TISSUE BARRIERS</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Sturgeon</surname>
<given-names>Craig</given-names>
</name>
<xref ref-type="aff" rid="af0001">
<sup>a</sup>
</xref>
<xref ref-type="aff" rid="af0002">
<sup>b</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fasano</surname>
<given-names>Alessio</given-names>
</name>
<xref ref-type="aff" rid="af0001">
<sup>a</sup>
</xref>
<xref ref-type="aff" rid="af0003">
<sup>c</sup>
</xref>
<xref ref-type="corresp" rid="an0001"></xref>
</contrib>
<aff id="af0001"><label>a</label><institution>Center for Celiac Research and Treatment, Mucosal Immunology and Biology Research Center, Massachusetts General Hospital and Division of Pediatric Gastroenterology and Nutrition</institution>, Boston, MA, <country>USA</country></aff>
<aff id="af0002"><label>b</label><institution>Graduate Program in Life Sciences, University of Maryland School of Medicine</institution>, Baltimore, MD, <country>USA</country></aff>
<aff id="af0003"><label>c</label><institution>European Biomedical Research Institute of Salerno (EBRIS)</institution>, Salerno, <country>Italy</country></aff>
</contrib-group>
<author-notes>
<corresp id="an0001"><bold>CONTACT</bold> Alessio Fasano, M.D. <email xlink:href="afasano@mgh.harvard.edu">afasano@mgh.harvard.edu</email><institution>Massachusetts General Hospital For Children</institution>, <addr-line>175 Cambridge St.</addr-line>, Boston, MA 02114, <country>USA</country></corresp>
</author-notes>
<pub-date pub-type="collection">
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>21</day>
<month>10</month>
<year>2016</year>
</pub-date>
<volume>4</volume>
<issue>4</issue>
<elocation-id seq="3">e1251384</elocation-id>
<history>
<date date-type="received">
<day>20</day>
<month>9</month>
<year>2016</year>
</date>
<date date-type="rev-recd">
<day>14</day>
<month>10</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>14</day>
<month>10</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>Â© 2016 Taylor &amp; Francis</copyright-statement>
<copyright-year>2016</copyright-year>
<copyright-holder>Taylor &amp; Francis</copyright-holder>
</permissions>
<self-uri content-type="pdf" xlink:href="ktib-04-04-1251384.pdf"></self-uri>
<abstract>
<title>ABSTRACT</title>
<p>Beside digesting nutrients and absorbing solutes and electrolytes, the intestinal epithelium with its barrier function is in charge of a tightly controlled antigen trafficking from the intestinal lumen to the submucosa. This trafficking dictates the delicate balance between tolerance and immune response causing inflammation. Loss of barrier function secondary to upregulation of zonulin, the only known physiological modulator of intercellular tight junctions, leads to uncontrolled influx of dietary and microbial antigens. Additional insights on zonulin mechanism of action and the recent appreciation of the role that altered intestinal permeability can play in the development and progression of chronic inflammatory disorders has increased interest of both basic scientists and clinicians on the potential role of zonulin in the pathogenesis of these diseases.</p>
<p>This review focuses on the recent research implicating zonulin as a master regulator of intestinal permeability linked to the development of several chronic inflammatory disorders.</p>
</abstract>
<kwd-group kwd-group-type="author">
<title>KEYWORDS</title>
<kwd>autoimmune disease</kwd>
<kwd>barrier function</kwd>
<kwd>intestinal permeability</kwd>
<kwd>tight junctions</kwd>
<kwd>zonulin</kwd>
</kwd-group>
<counts>
<fig-count count="3"></fig-count>
<table-count count="1"></table-count>
<ref-count count="153"></ref-count>
<page-count count="19"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>